share_log

B of A Securities Maintains Buy on Turnstone Biologics, Lowers Price Target to $10

B of A Securities Maintains Buy on Turnstone Biologics, Lowers Price Target to $10

B of A Securities维持对Turnstone生物制品的买入评级,将目标价下调至10美元。
Benzinga ·  08/19 12:46  · 评级/大行评级

B of A Securities analyst Geoff Meacham maintains Turnstone Biologics (NASDAQ:TSBX) with a Buy and lowers the price target from $12 to $10.

B of A证券分析师Geoff Meacham认为Turnstone Biologics(NASDAQ:TSBX)值得买入,并将目标价从$12降至$10。

声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发